COVID-19 blood clot mystery

impaired primary hemostasis, slowed platelet function, microvascular dysregulation

functional platelet defect without quantitative cytopenia

mitochondrial dysfunction, exhausted platelets, reduced aggregation capacity

energy dependent transport processes, drug handling, membrane homeostasis

distribution of drugs, metabolites, toxins, endogenous substances

chronic inflammation, endothelial activation, persistent immune activation

unstable coagulation, microthrombus turnover, “thrombo inflammatory” milieu

antifibrinolytic, microthrombus persistence, increased cardiovascular risk

inflammatory acute phase marker, increased viscosity, microthrombus tendency

endothelial stress, disturbed balance of pro  and anticoagulation, microvascular instability

“thrombo inflammatory” state with microthrombus turnover

no classic vWF syndrome, no secondary vWF deficiency constellation

confirms: primary hemostasis disorder is not located in the vWF system

small, rather “consumed” or less reactive platelets, chronic activation/consumption

impaired aggregation via ADP  and vWF dependent pathways, functional platelet defect

high prevalence of drug intolerance, risk of adverse reactions

clinically relevant intolerance, risk of severe reactions

post viral reactivation, chronic immune activation, endotheliitis

transient autoimmune/antiphospholipid activation, microthrombus risk

cold induced agglutination, microvascular risk, Raynaud amplification

microvascular spasms, digital ischemia, expression of endothelial/microcirculatory disorder

increased arrhythmia risk, ion channel dysfunction

MTHFR C677T and A1298C affect folate metabolism, methylation capacity, nitric‑oxide balance, endothelial stability, and thrombo‑inflammatory regulation. This places them directly on several of the axes already present in the table.

Alpha‑galactosidase is a lysosomal enzyme responsible for breaking down glycosphingolipids. Intermittently low levels indicate impaired lysosomal turnover, metabolic stress, and endothelial vulnerability.
This places it directly on several axes already present in the table.

metabolic dysregulation, cardiometabolic risk, endothelial function

A vasovagal reaction is an extreme form of this dysregulation: → sudden parasympathetic overactivity + drop in sympathetic tone → vasodilation + drop in blood pressure + microcirculatory collapse

This means that this axis lies exactly on the same systemic pathways as, for example:

• Endothelial stress
• Microthrombus dynamics
• Stress hormone reactivity
• Oxidative stress pathways
• Vascular permeability
• Microcirculation
• Thrombo-inflammatory systems

It is therefore another missing piece of the puzzle within the same architectural framework.

A possible relevant meaning in the context of the Andes hantavirus

The Andes hantavirus uses:
• endothelial permeability
• microcirculatory collapse
• stress‑hormone dysregulation
• thrombo‑inflammatory amplification
A vegetative vasoregulatory dysfunction means:
→ the virus encounters a system that is already unstable.
→ vasovagal patterns amplify the vascular permeability that the virus triggers anyway.
→ the microcirculation is more easily collapsible.
→ the stress‑hormone axis is hypersensitive.

Another thing that those affected have in common.

1. Increased proliferation = increased energy consumption (ATP pathway)
2. Increased proliferation = increased cytokine production (IL-6, TNF-α, IFN-γ)
3. Increased proliferation = more oxidative byproducts
4. Increased proliferation = more interaction with coagulation systems
5. Increased proliferation = more interaction with stress hormone axes
6. Increased proliferation = higher risk of viral reactivation

Thymidine kinase is a proliferation marker. Elevated TK indicates that lymphocytes are dividing rapidly and that the immune system is in a high‑activation, high‑turnover state.

Elevated TK = increased DNA synthesis = high lymphocyte turnover
This means:

• increased metabolic demand
• increased ATP consumption
• increased oxidative stress
• increased mitochondrial load

→ directly amplifies oxidative stress axes, ATP/PGX load, EPHX1, GST‑stress.

Elevated TK = strong cytokine production
Rapidly proliferating lymphocytes release:

• IL‑6
• TNF‑α
• IFN‑γ

These cytokines:

• activate the endothelium
• increase vascular permeability
• destabilize microcirculation
• increase fibrinogen and PAI‑1

→ directly amplifies endothelial stress, microthrombus dynamics, PAI‑1 axis.

• TH1 → IFN-γ, TNF-α → Endothelial activation
• TH2 → IL-4, IL-13 → Barrier disruption, permeability

= The ratio directly modulates the endothelial axis

TH1/TH2 influences microthrombus dynamics

• TH1 cytokines activate coagulation (tissue factor, thrombin)
• TH2 cytokines modulate fibrinolysis and PAI-1

= This ratio lies on the thrombo-inflammatory axis.

TH1/TH2 influences oxidative stress pathways

• TH1 → high ROS production
• TH2 → high levels of lipid mediators, epoxides

= correlates with EPHX1, GST stress, and oxidative epoxides

TH1/TH2 influences transporter/PGX activity
Cytokines regulate:

• ABC transporters
• SLC/OATP transporters
• mitochondrial metabolic pathways

= fits into the PGX pathway

GPIa/IIa (also known as integrin α2β1) is the platelet collagen receptor.
The C807T polymorphism influences how strongly platelets adhere to collagen under conditions of endothelial stress or microvascular injury.

This makes it directly relevant to the same biological axes described in your table:

• primary hemostasis
• platelet adhesion and signaling
• microcirculatory stability
• response to endothelial injury
• microthrombus dynamics

The C807T variant is associated with:

• differences in collagen‑induced platelet activation
• altered adhesion under high shear stress
• variability in thrombus formation in microvessels
• interaction with ATP‑dependent signaling pathways
• interaction with inflammatory and oxidative stress axes

different acetylator types, variable drug metabolism, toxicity risk

increased rate of severe drug reactions, autoimmune tendency

reduced detox capacity, increased oxidative stress, higher risk of chronic inflammation

altered adrenergic vascular response, blood pressure and vasomotor regulation

populations with altered drug distribution, toxicity, efficacy

definable subpopulation with high risk for microvascular, bleeding, and perfusion disorders

I was also able to identify this as a relevant (analog) parameter across the board.

DHEA is a key modulator of the stress hormone axis. DHEA acts as an antagonist to cortisol and adrenaline/noradrenaline.

This places it on the same axis as COMT

DHEA affects the endothelium, microcirculation, and vascular permeability = DHEA is a regulator of vascular and endothelial signaling pathways

DHEA affects coagulation and microthrombus dynamics

DHEA is part of the thrombo-inflammatory system.

Why this is also important in the case of hantaviruses — especially the Andes variant — they generate:
- oxidative stress
- vascular permeability
- microthrombus dynamics
- immune activation
- stress‑hormone responses

These axes overlap with:
- EPHX1 (oxidative epoxides
- COMT (stress hormones)
- GST deletion (detox capacity)
- ABC/SLC transporters (membrane transport)
- NAT2 (metabolism)

EPHX1 variants (particularly in exon 3) are associated with:

• endothelial dysfunction
• increased vascular permeability
• a tendency toward microthrombosis

Enhancing Interaction with Viral Activation/Reactivation
Covid 19/EBV/HHV6/CMV reactivation leads to increased production of oxidative epoxides.
When EPHX1 (exon 3) is reduced in activity:

• the burden on the endothelium increases
• the tendency toward microthrombosis increases
• platelet dysfunction worsens

The ability to detoxify reactive epoxides can be altered.
EPHX1 is critical for the degradation of:

• oxidative lipid epoxides
• toxic metabolites
• inflammation-associated epoxide intermediates

A functional impairment leads to increased oxidative stress, which:

• directly affects the endothelium
• platelets
• and microcirculation.

COMT V158M regulates the breakdown of catecholamines (dopamine, norepinephrine, epinephrine)
The V158M variant reduces the activity of the COMT enzyme by up to 75% = “Autonomous Regulation / Raynaud's / Microcirculation / Cold Agglutination” axis.
This means:

• higher norepinephrine levels
• higher epinephrine levels
• increased sympathetic activation
• prolonged stress response

COMT V158M enhances the thrombo-inflammatory axis
High catecholamine levels lead to:

• increased platelet reactivity
• increased endothelial permeability
• enhanced interaction between stress hormones and coagulation
• higher risk of microthrombosis

= PAI-1 4G/4G, fibrinogen ↑, PAP complex ↑, microthrombus turnover.

TRAP (Thrombin Receptor Activating Peptide)
TRAP is a diagnostic stimulus that specifically activates the PAR‑1 receptor on platelets.

It shows:
- how well platelets respond to thrombin‑like signals
- whether the intracellular ATP axis is functioning
- whether signal transduction / receptor pathways are impaired
- whether an aspirin‑like defect is present (COX/TXA2 axis)

→ TRAP belongs to the same axis as PFA‑100, ADP, ristocetin, ATP deficiency, ABC transporters, SLC/OATP.

C1‑Inhibitor (C1‑INH)
C1‑inhibitor is a central regulatory protein for:
- complement system (MBL Defect! = Lectin pathway ultra low or low)
- kallikrein‑kinin system (C1-INH inhibits plasma kallikrein → regulates bradykinin formation. Bradykinin is the most potent known mediator of vascular permeability)
- contact activation (factor XII)
- vascular permeability / bradykinin axis
- When these axes are overloaded (e.g., through oxidative stress, inflammation, viral reactivation), the following increase:
- vascular permeability
- microthrombus risk
- endothelial stress
- inflammatory activation

→ C1‑INH belongs to the same system logic as:
- endothelial stress
- Raynaud
- cold agglutination
- microcirculation
- EPHX1 (oxidative epoxides)
- COMT (stress hormones → vascular response)
- PAI‑1 4G/4G (antifibrinolytic)
→ C1‑INH is a regulator of these systems.

Factor XII (Hageman factor)
Factor XII is the starting point of the contact activation pathway of coagulation.

It is relevant because it:
- influences microthrombus formation, is activated by surface contact, inflammation, endothelial stress
is closely linked to the kallikrein‑kinin system, bradykinin, and vascular permeability
is more easily activated in the presence of endothelial stress + oxidative stress

→ Factor XII lies exactly at the intersection of:
- endothelial stress
- microthrombus dynamics
- vascular permeability
- inflammatory activation

This places it in the same system family as:
- PAP complex
- PAI‑1 4G/4G
- fibrinogen ↑
- microthrombus turnover
- EPHX1 (oxidative epoxides)
- COMT (stress hormones → vascular reactivity)

→ Factor XII is a marker of the “thrombo‑inflammatory axis.”

Salicylates interfere with COX and TXA2 signaling pathways
In the case of a systemic aspirin-like defect:

• COX-dependent signaling pathways are disrupted
• TXA2 production is altered
• Platelets react paradoxically or hypersensitively
• NSAIDs/ASA lead to overreactions

= Salicylates act precisely on this axis.
If the signaling pathways are already unstable, clinical intolerance develops.
PGX genes enhance the reaction (NAT2, HLA, ABC/SLC, EPHX1)
Salicylate intolerance is strongly associated with:

• NAT2 polymorphisms → slowed metabolism
• HLA-associated overreactions
• ABC/SLC transporter variants → altered distribution
• EPHX1 variants → more oxidative epoxides, more endothelial stress

Histamine intolerance is not an isolated phenomenon, but rather a manifestation of an overburdened, dysregulated multisystemic network.
DAO levels decrease during viral reactivation and inflammation
EBV/HHV-6/CMV lead to:

• Mast cell activation
• Decreased DAO levels
• Increased histamine release

COMT not only breaks down catecholamines, but also modulates:

• Mast cell activity
• Stress response
• Pain sensitivity
• Vascular reactivity

The V158M variant could lead to:

• higher norepinephrine
• stronger vasoconstriction
• stronger mast cell activation
• increased histamine release

Both intolerances (histamine + salicylates) are not isolated allergies/intolerances, but rather markers for:

• Endothelial stress
• Microvascular instability
• platelet signaling disorders
• ATP deficiency
• oxidative stress
• viral reactivation
• PGX vulnerability
• autonomic dysregulation
• impaired detoxification pathways

= cross-system mechanism

SOD2, CYP3A5 and CYP2C19 play a central role in this multisystemic phenotype because they influence three critical axes: oxidative stress, drug metabolism, and endothelial vulnerability. SOD2 variants (especially Ala16Val) reduce mitochondrial superoxide dismutase activity and lead to increased oxidative burden, which promotes ATP deficiency, endothelial stress, microthrombus tendency, and enhanced platelet activation – exactly matching the findings in your table. CYP3A5 polymorphisms (e.g., 3/3) alter the metabolism of numerous medications, influence endothelial exposure to toxic metabolites, and amplify intolerances to NSAIDs, analgesics, and antiviral substances. CYP2C19 variants modulate both the breakdown of medications (including proton pump inhibitors, antidepressants, clopidogrel) and the balance between inflammation, microcirculation, and platelet function. Together, these PGX profiles reinforce the combination of mitochondrial dysfunction, endothelial instability, thrombo‑inflammatory activation, and drug intolerances shown in the table and integrate seamlessly into the cross‑system model of the Geo Resilience Compass.

IgG2 is the immunoglobulin subtype that is primarily responsible for the defense against encapsulated bacteria (e.g., pneumococci), polysaccharide antigens, and certain viral structures. An IgG2 weakness or dysregulation leads to reduced control of chronic or reactivated infections and thereby promotes a persistent inflammatory milieu. This inflammatory environment amplifies endothelial stress, microthrombus turnover, fibrinolytic dysregulation, and activation of the thrombo‑inflammatory axis, as already shown in the table. In addition, IgG2 functionally interacts with HLA‑associated immune reactions, oxidative stress (SOD2), viral reactivation (e. g. EBV/HHV6/CMV), and PGX profiles that modulate immune regulation. Thus, IgG2 is an immunological marker for the lack of system coherence between infection control, endothelial function, hemostasis, and microcirculation and integrates seamlessly into the cross‑system model of the Geo Resilience Compass.

MMP‑1 and MMP‑3 are key matrix metalloproteinases that regulate the integrity of the extracellular vascular matrix, endothelial function, and the inflammatory microenvironment. Genetic variants or increased activity of these MMPs lead to enhanced degradation of collagen and matrix proteins, which destabilizes the vessel wall, increases permeability, and intensifies the interaction between endothelium, immune cells, and the coagulation system. MMP‑1 and MMP‑3 are closely linked to chronic inflammation, viral acitivation/reactivation (Covid19/EBV/HHV6/CMV), oxidative stress (SOD2), PAI‑1‑mediated fibrinolytic dysregulation, and microthrombus turnover. They also modulate the activation of cytokines and growth factors, further amplifying the thrombo‑inflammatory axis. Thus, MMP‑1 and MMP‑3 also integrate seamlessly into the multisystemic pattern of endothelial instability, microcirculatory disturbance, hemostatic dysregulation, and PGX‑dependent vulnerability.